A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (4) , 639-652
- https://doi.org/10.1016/s0149-2918(02)85139-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antibiotics Are Associated With Lower Relapse Rates in Outpatients With Acute Exacerbations of COPDChest, 2000
- Future antibiotic trialsSeminars in Respiratory Infections, 2000
- The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 2000
- Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg BID versus clarithromycin 500 mg BIDClinical Therapeutics, 1998
- Acute Exacerbations of Chronic BronchitisChest, 1998
- A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic BronchitisChest, 1998
- Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysisJAMA, 1995
- Use of quinolones for the treatment of acute exacerbations of chronic bronchitisThe American Journal of Medicine, 1991
- Treatment of acute exacerbations of chronic bronchitis: State of the artThe American Journal of Medicine, 1991
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987